Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Research Council grant · Running

STAIN-IT Non-invasive computational immunohistochemical staining based on deep learning and multimodal imaging

Coordinator
Leibniz-Institut Fuer Photonische Technologien E.v., Germany
Runs
1 September 2023 to 31 August 2028
Status
Running
EU funding
€2.0m
Total cost
€2.0m
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101088997

What the project is doing

In the project's own words, from its summary on CORDIS.

In most European countries, the diagnosis of cancer is achieved by examination of haematoxylin-eosin (HE) staining by an experienced pathologist. Nevertheless, several other diagnostic approaches exist (e.g., immunohistochemical staining) which are not applied routinely for all cases due to their technical complexity, duration, and cost. Therefore, an important unmet medical need for fast, non-invasive, and label-free immunohistochemical staining based on molecular imaging without laborious sample treatment exists.

This demanding challenge will be tackled in STAIN-IT using a non-invasive label-free measurement technique called multimodal imaging (e.g., the combination of coherent anti-Stokes Raman scattering, second harmonic generation, and two-photon-excited fluorescence). The multimodal images will be analysed using deep learning approaches, such as convolution neural networks (CNNs). These CNNs are utilized to mimic immunohistochemical stainings.

CNNs are neural networks that learn the feature representation of the data, which is optimally suited to model a specific immunohistochemical staining. In STAIN-IT, the staining models will be developed along with the methods to quantitatively understand the nonlinear behaviour of the CNNs. With the envisioned approximation approaches for CNNs, these models no longer act as black box systems, and a quantification of tissue changes associated with the staining models can be achieved.

For the very first time, STAIN-IT will develop a label-free, non-invasive, labour-inexpensive, and fast computational immunohistochemical staining, which can be easily implemented into clinical routine yielding increased diagnostic reliability and a better understanding of disease pathogenesis. A fast test of the antigen KI-67 in an intraoperative frozen section consultation situation or the use of Collagen IV as a quality control marker of tissue-engineered medicines are some of the exciting application possibilities of such staining model.

Topics

Who is involved

OrganisationCityCountryRole
Leibniz-Institut Fuer Photonische Technologien E.v.JenaGermanyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI